Compare · EW vs XPEL
EW vs XPEL
Side-by-side comparison of Edwards Lifesciences Corporation (EW) and XPEL Inc. (XPEL): market cap, price performance, sector, and recent activity on the wire.
Summary
- EW operates in Health Care, while XPEL operates in Industrials - the two are in different parts of the market.
- EW is the larger of the two at $50.78B, about 41.6x XPEL ($1.22B).
- EW has been more active in the news (5 items in the past 4 weeks vs 3 for XPEL).
- EW has more recent analyst coverage (25 ratings vs 3 for XPEL).
- Company
- Edwards Lifesciences Corporation
- XPEL Inc.
- Price
- -
- -
- Market cap
- $50.78B
- $1.22B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 5
- 3
- Recent ratings
- 25
- 3
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
XPEL Inc.
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Latest EW
- SEC Form 4 filed by Edwards Lifesciences Corporation
- Barclays initiated coverage on Edwards Lifesciences with a new price target
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
- SVP, Corporate Controller Dahl Andrew M. covered exercise/tax liability with 253 shares, decreasing direct ownership by 2% to 14,615 units (SEC Form 4) to satisfy withholding tax
- CVP, JAPAC Markowitz Wayne covered exercise/tax liability with 923 shares, decreasing direct ownership by 5% to 19,371 units (SEC Form 4) to satisfy tax liability
- CVP, TAVR Lippis Daniel J. exercised 619 shares at a strike of $72.68 and sold $54,169 worth of shares (619 units at $87.51) as part of a pre-agreed trading plan (SEC Form 4)
- CVP, TMTT, Surgical & IHFM Chopra Daveen covered exercise/tax liability with 398 shares, decreasing direct ownership by 0.90% to 43,926 units (SEC Form 4) to satisfy tax liability
- Edwards Lifesciences Comments on TAVR National Coverage Decision
Latest XPEL
- Amendment: SEC Form SCHEDULE 13G/A filed by XPEL Inc.
- SEC Form 4 filed by XPEL Inc.
- SEC Form 4 filed by XPEL Inc.
- Director North John F converted options into 441 shares, increasing direct ownership by 4% to 10,716 units (SEC Form 4)
- Director Bogart Stacy L converted options into 441 shares, increasing direct ownership by 5% to 8,907 units (SEC Form 4)
- 34 Miles Out to Sea, Nowhere to Hide from the Sun: Tint World® and XPEL Team Up to Protect Historic Frying Pan Shoals Tower
- Amendment: SEC Form SCHEDULE 13G/A filed by XPEL Inc.
- XPEL and Will Castro Return for Season 2 of 'Unique Academy USA,' Expanding Reach of Transformative Automotive Career Program
- SEC Form 10-Q filed by XPEL Inc.
- XPEL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits